AnalyzeDirect Cristina Sánchez Carabias et al. Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury. Journal of Intensive Care Medicine.
Publication Date
April 8, 2019
How Analyze was Used
“Biomarkers were quantified by enzyme-linked immunosorbent assay. Intracranial lesion volume was measured from the semiautomatic segmentation of hematoma on computed tomography (CT) using Analyze software.”
Keywords
Traumatic brain injury (TBI), Biomarkers, Serum amyloid A1 (SAA1), Secondary insults, Inflammation, Outcome
Author Affiliation(s)
Hospital 12 de Octubre, Madrid, Spain
